novel

Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology

Source Node:
Time Stamp: April 15, 2024 1:26 PM - Modified On: April 15, 2024 - Published By:
Source Cluster:
Republished By Plato

  Company is targeting pancreatic cancer pain with advanced nerve detection and treatment technology New York, March 12, 2024 - (Plato Data) - Benzinga has published a new article on Autonomix Medical Inc. (NASDAQ: AMIX), featuring the company's groundbreaking approach to peripheral nervous system (PNS) disorders. The Benzinga article delves into the critical role of the PNS in human health and highlights how Autonomix Medical is pioneering with its catheter-based microchip sensing array technology. The article provides a comprehensive look at how Autonomix Medical is redefining treatment protocols for nerve-related

Life DeFi Partners with Alvara Protocol to Integrate ERC 7621 Basket Token Standard

Source Node:
Time Stamp: March 12, 2024 5:51 AM - Modified On: March 12, 2024 - Published By:
Source Cluster:
Republished By Plato

[Seychelles] — In a significant stride towards enhancing DeFi accessibility and functionality, Life DeFi is thrilled to announce a partnership with Alvara Protocol. This collaboration marks the integration of the innovative ERC 7621 standard into Life DeFi’s mobile and Chrome extension wallets, setting a new standard in the DeFi ecosystem. Alvara Protocol introduces a novel approach to managing and investing in digital assets. By allowing users to create, manage, and trade baskets of tokens, it simplifies the investment process, offering a diversified approach directly within Life DeFi’s platforms. Streamlining DeFi

D8X Re-Engineers DeFi Derivatives With Launch on Polygon zkEVM

Source Node:
Time Stamp: February 6, 2024 2:05 PM - Modified On: February 6, 2024 - Published By:
Source Cluster:
Republished By Plato

  Supported by Polygon Ventures, D8X targets institutional users with next-gen DEX engine, innovative features, novel white-label approach [Zug, Switzerland - Feb. 6, 2024] - D8X, an institutional-grade decentralized exchange (DEX) for derivatives, has launched on Polygon zkEVM, establishing a new benchmark for decentralized finance. With support from Polygon Ventures and other notable partners, D8X reconceives on-chain derivatives, starting from fundamental financial engineering and extending to its novel white-label business-to-business model–a first for Polygon zkEVM. Until now, users seeking the trading experience offered by D8X have had to resort to

Tokens Fueling Innovation in the Dynamic Fantom DeFi Ecosystem

Source Node:
Time Stamp: January 11, 2024 11:56 AM - Modified On: January 11, 2024 - Published By:
Source Cluster:
Republished By Plato

In the rapidly evolving realm of Defi and L1’s, the Fantom ecosystem shines as a vibrant hub for innovation. Within this dynamic landscape, various protocols play pivotal roles in sculpting the future of decentralized finance on Fantom. Each protocol brings its distinct features, vision, and potential to the forefront, propelling growth, stability, and inclusivity within the Fantom DeFi ecosystem. The most known protocol in Fantom is SpookySwap (Ticker : BOO), an EVM-compatible DEX, has been pioneered since its April 2021 launch. Endorsed by the Fantom Foundation and bolstered by community

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

Source Node:
Time Stamp: October 13, 2023 5:17 AM - Modified On: October 13, 2023 - Published By:
Source Cluster:
Republished By Plato

  In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis

Revolutionizing Tourism with Web3: A Landmark Partnership Between Camino Network, DCM Swiss, 1World Online, and Web3-Solutions

Source Node:
Time Stamp: October 12, 2023 12:02 PM - Modified On: October 12, 2023 - Published By:
Source Cluster:
Republished By Plato

In an unprecedented-opportunity-driven move, four innovative companies in the travel and marketing sectors — Camino Network, initiated by Chain4Travel, DCM Swiss, 1World Online, and Web3-Solutions — have come together to announce a landmark partnership. This alliance aims to harness cutting-edge technologies in reshaping the future of travel and tourism experiences and bringing new monetization options and benefits to all ecosystem participants. We are happy to announce that: DCM Swiss and 1World Online are becoming Validators at Camino Network. Web3-Solutions becomes a Regional Partner of DCM: A regional partnership agreement has

Malaysian Genomics to Collaborate on Cannabinoid R&D

Source Node:
Time Stamp: February 24, 2023 7:08 AM - Modified On: February 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Group joins MAHSA University and Kensana Health to develop phytopharmaceutical and biotechnology products for commercialisation PETALING JAYA, Malaysia, Feb 24, 2023 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group has entered into a strategic collaboration with Kensana Health Canada and MAHSA University for the research and development (R&D) of phytopharmaceutical and biotechnology products that can lead to commercialisation. [caption id="attachment_1975650" align="alignnone" width="350"] Dato' Alvin Joseph Nesakumar, Executive Director of Malaysian Genomics[/caption] Kensana Health Canada is a biotechnology specialist

VNX Gold token now available on LBank, expanding global interest in gold-backed digital assets

Source Node:
Time Stamp: November 2, 2022 12:50 PM - Modified On: November 2, 2022 - Published By:
Source Cluster:
Republished By Plato

[vc_row][vc_column][vc_column_text]Leading cryptocurrency exchange LBank, adds VNX Gold to its platform, becoming one of the exchanges to offer VNX’s asset-backed token tied to precious metals[/vc_column_text][vc_gallery type="flexslider_slide" interval="0" images="1733853,1733847,1733848,1733849,1733850,1733851,1733852" img_size="full" onclick=""][vc_column_text]Liechtenstein, November 2022 — VNX, Europe’s first regulated platform for investing in tokenized precious metals, announces that VNX Gold token is available on a top virtual asset exchange LBank. VNX Gold tokens represent an ownership stake of physical gold bullion certified by the London Bullion Market Association (LBMA). As the premier token of the VNX platform, VNX Gold empowers users to invest